Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer

Completed · Phase 1

Conditions studied: Prostate Cancer

In brief

RATIONALE: Drugs used in chemotherapy, such as liposomal doxorubicin, use different ways to stop tumor cells from dividing so they stop growing or die. Microwave thermotherapy kills tumor cells by heating them to several degrees above body temperature. Combining liposomal doxorubicin with microwave thermotherapy may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of liposomal doxorubicin when given together with microwave thermotherapy in treating patients with prostate cancer.

Key facts

Study ID

NCT00061867

Run by

Imunon

Starts

2003-03-01

Expected to finish

2005-08-01

Last updated by the study team

2013-05-30

Who can join

Age: 40 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Regional Urology, L.L.C. — Shreveport, Louisiana, United States
• Grand Strand Urology LLP — Myrtle Beach, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.